首页> 外文OA文献 >Hematopoietic stem cell transplantation: Improving alloreactive Bw4 donor selection by genotyping codon 86 of KIR3DL1/S1
【2h】

Hematopoietic stem cell transplantation: Improving alloreactive Bw4 donor selection by genotyping codon 86 of KIR3DL1/S1

机译:造血干细胞移植:通过对KIR3DL1 / S1的86号密码子进行基因分型来改善同种反应性Bw4供体的选择

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

KIR3DL1 is a natural killer (NK) cell receptor that recognizes the Bw4 epitope of human leukocyte antigen (HLA) class I molecules. Following hematopoietic stem cell transplantation for patients lacking Bw4, KIR3DL1-expressing NK cells from Bw4-positive donors can be alloreactive and eliminate tumor cells. However, KIR3DL1 alleles having T instead of C at nucleotide 320 (encoding leucine 86 instead of serine 86) are not expressed on the cell surface. Thus, not all individuals testing positive for KIR3DL1 are optimal donors for Bw4-negative recipients. Therefore, we developed a method for genotyping codon 86, which was validated by its perfect correlation with NK cell phenotype for 100 donors of diverse KIR3DL1/S1 genotype. We typed 600 donors and found that ∼12.2% had the KIR3DL1 gene, but did not express cell-surface KIR3DL1. By contrast, high-expressing allotypes were identified when haplotypes from four families with duplicated KIR3DL1/S1 genes were characterized at high resolution. Identifying donors who have KIR3DL1 but lack cell-surface KIR3DL1 would refine donor selection. With this technique, the number of individuals identified who may not be optimal donors for Bw4-negative patients increases by threefold, when compared with standard methods. Taken together, we propose that allele typing of killer cell Ig-like receptor (KIR) polymorphisms should become a standard practice when selecting donors.
机译:KIR3DL1是一种天然杀伤(NK)细胞受体,可识别人白细胞抗原(HLA)I类分子的Bw4表位。对于缺乏Bw4的患者进行造血干细胞移植后,来自Bw4阳性供体的表达KIR3DL1的NK细胞可能具有同种反应性并消除了肿瘤细胞。但是,在核苷酸320上具有T而不是C的KIR3DL1等位基因(编码亮氨酸86而不是丝氨酸86)不在细胞表面表达。因此,并非所有测试KIR3DL1阳性的个体都是Bw4阴性受体的最佳供体。因此,我们开发了一种86型密码子分型方法,该方法通过与100种不同KIR3DL1 / S1基因型供体的NK细胞表型完美相关而得到验证。我们输入了600个供体,发现〜12.2%的人具有KIR3DL1基因,但不表达细胞表面的KIR3DL1。相比之下,当来自四个具有重复KIR3DL1 / S1基因的家族的单倍型以高分辨率表征时,鉴定出了高表达的同种型。鉴定具有KIR3DL1但缺乏细胞表面KIR3DL1的供体将改善供体选择。与标准方法相比,通过这种技术,被确定为Bw4阴性患者的最佳供者的个体数量增加了三倍。综上所述,我们建议选择供体时,杀伤细胞Ig样受体(KIR)多态性的等位基因分型应成为一种标准做法。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号